Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson's Disease or Dementia

10Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

Abstract

Our primary objective was to understand the barriers and facilitators associated with the implementation of high-quality clinical practice guidelines (CPGs) for depression and anxiety in patients with dementia or Parkinson's disease (PD). We conducted focus groups or interviews with participants experiencing dementia or PD, their caregivers, and physicians in Calgary, Alberta, and applied the theoretical domains framework and behaviour change wheel to guide data collection and perform a framework analysis. Thirty-three physicians and seven PD patients/caregivers participated. We report barriers and facilitators to the implementation of guideline recommendations for diagnosis, management, and the use of the guidelines. An overarching theme was the lack of evidence for depression or anxiety disorders in dementia or PD, which was prominent for anxiety versus depression. Patients noted difficulties with communicating symptoms and accessing services. Although guidelines are available, physicians have difficulty implementing certain recommendations due primarily to a lack of evidence regarding efficacy.

Cite

CITATION STYLE

APA

Goodarzi, Z., Hanson, H. M., Jette, N., Patten, S., Pringsheim, T., & Holroyd-Leduc, J. (2018). Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson’s Disease or Dementia. Canadian Journal on Aging, 37(2), 185–199. https://doi.org/10.1017/S0714980818000053

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free